Expression and significance of bone sialoprotein and matrix metalloproteinase-9 in calcified metral valves of rheumatic heart disease
10.3760/cma.j.issn.1008-6315.2012.10.015
- VernacularTitle:骨唾液蛋白和基质金属蛋白酶-9在风湿性心脏病瓣膜的表达及意义
- Author:
Chuanming BAI
;
Bin ZHANG
;
Nan ZHANG
;
Shutian SONG
;
Zhigang ZHANG
;
Yuqing BIAN
;
Jiewu ZHOU
- Publication Type:Journal Article
- Keywords:
Bone sialoprotein;
Matrix metalloproteinase-9;
Rheumatic heart disease
- From:
Clinical Medicine of China
2012;28(10):1056-1058
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression and significance of bone sialoprotein and matrix metalloproteinase-9 in calcified mitral valves in patients with rheumatic heart disease.Methods A total of 150 mitral valves were divided into the rheumatic group (n =120) and the non-rheumatic group (n =30 ).Expressions of bone sialoprotein and matrix metalloproteinase-9 were determined by immunohistochemistry.Results Expressions of bone sialoprotein ( 91.6%,x2 =56.6354 ) and matrix metalloproteinase-9 ( 90.8%,x2 =59.4272) in the rheumatic group increased significantly than in the non-rheumatic group (P < 0.01).Conclusion Both bone sialoprotein and matrix metalloproteinase-9 are highly expressed in the calcified rheumatic group.This suggests that caficify of rheumatic mitral valves is related with the degradation and remodeling of extra cellular matricx by matrix metalloproteinase-9,as well as osteoblastlike bone formation by bone sialoprotein.